acetylcysteine has been researched along with levofloxacin in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
del Carmen Ponte, M; del Prado, G; Naves, P; RodrÃguez-Cerrato, V; Ruiz, V; Soriano, F | 1 |
Cadle, RM; Darouiche, RO; Hull, RA; Mansouri, MD; Stager, CE | 1 |
de Oliveira, AC; de Sousa, JKT; Dos Santos, SG; Haddad, JPA; Vieira, CD | 1 |
Hull, RA; Mansouri, DL; Mansouri, MD; Ramanthan, V | 1 |
1 review(s) available for acetylcysteine and levofloxacin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for acetylcysteine and levofloxacin
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N-acetyl-l-cysteine, amoxicillin, erythromycin, and levofloxacin.
Topics: Acetylcysteine; Amoxicillin; Anti-Bacterial Agents; Biofilms; Erythromycin; Humans; Ibuprofen; Levofloxacin; Ofloxacin; Serum Albumin; Streptococcus pneumoniae | 2010 |
In vitro activity and durability of a combination of an antibiofilm and an antibiotic against vascular catheter colonization.
Topics: Acetylcysteine; Anti-Infective Agents; Biofilms; Colony Count, Microbial; Drug Combinations; Equipment Contamination; Gram-Negative Bacteria; Gram-Positive Bacteria; Levofloxacin; Ofloxacin; Vascular Access Devices | 2013 |
In vitro activity of antimicrobial-impregnated catheters against biofilms formed by KPC-producing Klebsiella pneumoniae.
Topics: Acetylcysteine; Anti-Bacterial Agents; Biofilms; Catheters; Chlorhexidine; Drug Resistance, Bacterial; Klebsiella pneumoniae; Levofloxacin; Silver Sulfadiazine; Time Factors | 2019 |
In vitro activities of N-acetyl cysteine and levofloxacin as a catheter lock therapy against catheter-associated infections.
Topics: Acetylcysteine; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Catheter-Related Infections; Catheters; Escherichia coli; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Staphylococcus aureus | 2022 |